Hôpital régional de Rimouski

Rimouski, Quebec G5L 5T1

0 studies enrolling now · 3 studies all time

What they study most

ARDS, Amyloid Cardiomyopathy, Amyloid Cardiomyopathy, Transthyretin-Related, Amyloidosis, COVID-19, Cardiomyopathies, Heart Diseases, Transthyretin Amyloidosis

Studies at this site

• Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants — Running, not enrolling
• A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC Vs. Placebo + SOC in Adult Hospitalized Patients with COVID-19 — Paused
• Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy — Completed